Quick Heal Technologies Limited (QUICKHEAL)
Analysts/Institutional Investor Meet/Con. Call Updates
AI summary
- Q2 FY27 consolidated revenue INR 65 Cr, +44% q-q, -22% y-y
- Enterprise revenue INR 35 Cr, +18% q-q, -4% y-y; Consumer INR 36 Cr, +86% q-q, -40% y-y
- EBITDA turned positive INR 2.3 Cr vs loss INR 17.6 Cr in Q1; PAT INR 5.8 Cr vs loss INR 5.3 Cr
- Focus on enterprise market growth, aiming >80% revenue from enterprise in 3 years
- Challenges: consumer decline due to OS vendor policies; enterprise market fragmented, targeting SMB segment
- DPDP data privacy offering launched, seen as medium-long term growth driver
- International presence in 70+ countries; selective expansion ongoing
- Cost optimization ongoing with stable employee costs
- AI-driven cyberattacks increasing enterprise demand; no consumer demand uptick expected
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 QUICKHEAL — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add QUICKHEAL to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Quick Heal Technologies Limited
Important.
The summary above is generated automatically from Quick Heal Technologies Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.